Cambridge Cancer Genomics

Predicta Biosciences

This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.

Oncobit

This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.

Mirada Medical

This company develops medical imaging software for clinicians to improve cancer diagnosis, treatment planning and radiotherapy workflows.

GenomOncology

This company develops software platforms to analyse and interpret genomic data for molecular pathology labs, clinical oncologists and research institutions.

Oxford Cancer Biomarkers

This company develops and commercialises precision diagnostic tests and digital pathology tools to help clinicians personalise cancer treatment and assess patient toxicity risks.

Cyclomics

This biotechnology firm develops DNA sequencing and AI-powered diagnostic software for clinicians and researchers to detect cancer and classify tumours using liquid biopsies.

LiquidCell Dx

This company develops blood-based liquid biopsy tests for tumor microenvironment profiling to help pharmaceutical companies and clinical partners predict cancer therapy responses.

OXCan

This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.